SIRPA and melanoma: Studies in other cell types, including kidney podocytes and melanoma cells, suggested that SIRPα maintains tyrosine phosphorylation in the cytoplasmic domain and association with SHP-(1/2); cell surface CD47 ligation, on the other hand, triggers SIRPα dephosphorylation and releases SHP proteins [4,41].